Literature DB >> 24587616

Multifunctional to multistage delivery systems: The evolution of nanoparticles for biomedical applications.

Jonathan O Martinez1, Brandon S Brown1, Nicoletta Quattrocchi2, Michael Evangelopoulos2, Mauro Ferrari2, Ennio Tasciotti2.   

Abstract

Nanomaterials are advancing in several directions with significant progress being achieved with respect to their synthesis, functionalization and biomedical application. In this review, we will describe several classes of prototypical nanocarriers, such as liposomes, silicon particles, and gold nanoshells, in terms of their individual function as well as their synergistic use. Active and passive targeting, photothermal ablation, and drug controlled release constitute some of the crucial functions identified to achieve a medical purpose. Current limitations in targeting, slow clearance, and systemic as well as local toxicity are addressed in reference to the recent studies that attempted to comprehend and solve these issues. The demand for a more sophisticated understanding of the impact of nanomaterialson the body and of their potential immune response underlies this discussion. Combined components are then discussed in the setting of multifunctional nanocarriers, a class of drug delivery systems we envisioned, proposed, and evolved in the last 5 years. In particular, our third generation of nanocarriers, the multistage vectors, usher in the new field of nanomedicine by combining several components onto multifunctional nanocarriers characterized by emerging properties and able to achieve synergistic effects.

Entities:  

Keywords:  cancer; drug delivery; multifunctional; multistage; nanomedicine; nanoparticle; porous silicon; third generation nanocarriers

Year:  2012        PMID: 24587616      PMCID: PMC3938208          DOI: 10.1007/s11434-012-5387-5

Source DB:  PubMed          Journal:  Chin Sci Bull        ISSN: 1001-6538


  80 in total

1.  Immunotargeted nanoshells for integrated cancer imaging and therapy.

Authors:  Christopher Loo; Amanda Lowery; Naomi Halas; Jennifer West; Rebekah Drezek
Journal:  Nano Lett       Date:  2005-04       Impact factor: 11.189

Review 2.  Multifunctional nanoparticles--properties and prospects for their use in human medicine.

Authors:  Nuria Sanvicens; M Pilar Marco
Journal:  Trends Biotechnol       Date:  2008-08       Impact factor: 19.536

3.  pH-Triggered controlled drug release from mesoporous silica nanoparticles via intracelluar dissolution of ZnO nanolids.

Authors:  Faheem Muhammad; Mingyi Guo; Wenxiu Qi; Fuxing Sun; Aifei Wang; Yingjie Guo; Guangshan Zhu
Journal:  J Am Chem Soc       Date:  2011-05-23       Impact factor: 15.419

4.  Cellular association and assembly of a multistage delivery system.

Authors:  Rita E Serda; Aaron Mack; Merlyn Pulikkathara; Ana Maria Zaske; Ciro Chiappini; Jean R Fakhoury; Douglas Webb; Biana Godin; Jodie L Conyers; Xue W Liu; James A Bankson; Mauro Ferrari
Journal:  Small       Date:  2010-06-21       Impact factor: 13.281

5.  Logic-embedded vectors for intracellular partitioning, endosomal escape, and exocytosis of nanoparticles.

Authors:  Rita E Serda; Aaron Mack; Anne L van de Ven; Silvia Ferrati; Kenneth Dunner; Biana Godin; Ciro Chiappini; Matthew Landry; Louis Brousseau; Xuewu Liu; Andrew J Bean; Mauro Ferrari
Journal:  Small       Date:  2010-10-18       Impact factor: 13.281

6.  Tailored porous silicon microparticles: fabrication and properties.

Authors:  Ciro Chiappini; Ennio Tasciotti; Jean R Fakhoury; Daniel Fine; Lee Pullan; Young-Chung Wang; Lianfeng Fu; Xuewu Liu; Mauro Ferrari
Journal:  Chemphyschem       Date:  2010-04-06       Impact factor: 3.102

Review 7.  Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats.

Authors:  Michelle Longmire; Peter L Choyke; Hisataka Kobayashi
Journal:  Nanomedicine (Lond)       Date:  2008-10       Impact factor: 5.307

8.  Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer.

Authors:  M E R O'Brien; N Wigler; M Inbar; R Rosso; E Grischke; A Santoro; R Catane; D G Kieback; P Tomczak; S P Ackland; F Orlandi; L Mellars; L Alland; C Tendler
Journal:  Ann Oncol       Date:  2004-03       Impact factor: 32.976

Review 9.  Antibiological barrier nanovector technology for cancer applications.

Authors:  Jason Sakamoto; Ananth Annapragada; Paolo Decuzzi; Mauro Ferrari
Journal:  Expert Opin Drug Deliv       Date:  2007-07       Impact factor: 6.648

10.  Selective prostate cancer thermal ablation with laser activated gold nanoshells.

Authors:  Joshua M Stern; Jennifer Stanfield; Wareef Kabbani; Jer-Tsong Hsieh; Jeffrey A Cadeddu
Journal:  J Urol       Date:  2007-12-20       Impact factor: 7.450

View more
  16 in total

1.  Multistage Nanovectors Enhance the Delivery of Free and Encapsulated Drugs.

Authors:  Jonathan O Martinez; Michael Evangelopoulos; Rohan Bhavane; Stefania Acciardo; Francesco Salvatore; Xuewu Liu; Mauro Ferrari; Ennio Tasciotti
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

Review 2.  Inflammation and Cancer: In Medio Stat Nano.

Authors:  Roberto Molinaro; Claudia Corbo; Megan Livingston; Michael Evangelopoulos; Alessandro Parodi; Christian Boada; Marco Agostini; Ennio Tasciotti
Journal:  Curr Med Chem       Date:  2018       Impact factor: 4.530

3.  Ultrasound shear wave elastography effectively predicts integrity of ventral hernia repair using acellular dermal matrix augmented with platelet-rich plasma (PRP).

Authors:  Jeffrey L Van Eps; Anuj Chaudhry; Joseph S Fernandez-Moure; Christian Boada; Vishwanath Chegireddy; Fernando J Cabrera; Songyuan Tang; Ennio Tasciotti; Raffaella Righetti
Journal:  Surg Endosc       Date:  2018-12-13       Impact factor: 4.584

4.  Chlorin e6 Functionalized Theranostic Multistage Nanovectors Transported by Stem Cells for Effective Photodynamic Therapy.

Authors:  Simo Näkki; Jonathan O Martinez; Michael Evangelopoulos; Wujun Xu; Vesa-Pekka Lehto; Ennio Tasciotti
Journal:  ACS Appl Mater Interfaces       Date:  2017-07-05       Impact factor: 9.229

5.  The effect of multistage nanovector targeting of VEGFR2 positive tumor endothelia on cell adhesion and local payload accumulation.

Authors:  Jonathan O Martinez; Michael Evangelopoulos; Vivek Karun; Evan Shegog; Joshua A Wang; Christian Boada; Xuewu Liu; Mauro Ferrari; Ennio Tasciotti
Journal:  Biomaterials       Date:  2014-08-28       Impact factor: 12.479

Review 6.  The Emerging Role of Nanotechnology in Cell and Organ Transplantation.

Authors:  Ennio Tasciotti; Fernando J Cabrera; Michael Evangelopoulos; Jonathan O Martinez; Usha R Thekkedath; Malgorzata Kloc; Rafik M Ghobrial; Xian C Li; Alessandro Grattoni; Mauro Ferrari
Journal:  Transplantation       Date:  2016-08       Impact factor: 4.939

7.  Cell source determines the immunological impact of biomimetic nanoparticles.

Authors:  Michael Evangelopoulos; Alessandro Parodi; Jonathan O Martinez; Iman K Yazdi; Armando Cevenini; Anne L van de Ven; Nicoletta Quattrocchi; Christian Boada; Nima Taghipour; Claudia Corbo; Brandon S Brown; Shilpa Scaria; Xuewu Liu; Mauro Ferrari; Ennio Tasciotti
Journal:  Biomaterials       Date:  2015-12-02       Impact factor: 12.479

8.  Photopolymerization-based synthesis of iron oxide nanoparticle embedded PNIPAM nanogels for biomedical applications.

Authors:  Daniel J Denmark; Robert H Hyde; Charlotte Gladney; Manh-Huong Phan; Kirpal S Bisht; Hariharan Srikanth; Pritish Mukherjee; Sarath Witanachchi
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

9.  Development and Characterization of PLGA-Based Multistage Delivery System for Enhanced Payload Delivery to Targeted Vascular Endothelium.

Authors:  Jorge A Palma-Chavez; Kevin Fuentes; Brian E Applegate; Javier A Jo; Phapanin Charoenphol
Journal:  Macromol Biosci       Date:  2021-01-04       Impact factor: 5.859

Review 10.  Nanomedicine concepts in the general medical curriculum: initiating a discussion.

Authors:  Aldrin E Sweeney
Journal:  Int J Nanomedicine       Date:  2015-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.